A multimarker risk stratification approach to non‐ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro‐BNP and fibrin D‐dimer levels

Abstract.  Tello‐Montoliu A, Marín F, Roldán V, Mainar L, López MT, Sogorb F, Vicente V, Lip GYH (Hospital General Universitario, Alicante; Hospital Morales Meseguer, Murcia; Hospital de Requena, Valencia; Hospital General Universitario, Alicante, Spain and City Hospital, Birmingham, UK). A multimarker risk stratification approach to non‐ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro‐BNP and fibrin D‐dimer levels. J Intern Med 2007; 262: 651–658.

[1]  L. Sokoll,et al.  A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[2]  J. Ambrose,et al.  Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes. , 2005, The American journal of cardiology.

[3]  J. Núñez,et al.  Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes. , 2005, American heart journal.

[4]  T. van der Poll,et al.  Bidirectional Relation Between Inflammation and Coagulation , 2004, Circulation.

[5]  M. Galvani,et al.  Natriuretic peptides for risk stratification of patients with acute coronary syndromes , 2004, European journal of heart failure.

[6]  G. Lip,et al.  Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new ‘vascular triad’ , 2004, Annals of medicine.

[7]  R. Califf,et al.  N‐Terminal Pro‐Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)‐IV Substudy , 2003, Circulation.

[8]  David A Morrow,et al.  Future of Biomarkers in Acute Coronary Syndromes Moving Toward a Multimarker Strategy , 2003, Circulation.

[9]  J. Herlitz,et al.  N-Terminal Pro-B-Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary Syndromes , 2002, Circulation.

[10]  G. Specchia,et al.  Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2002, European heart journal.

[11]  A. Laggner,et al.  Evaluation of coagulation markers for early diagnosis of acute coronary syndromes in the emergency room. , 2002, Clinical chemistry.

[12]  Nader Rifai,et al.  Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide , 2002, Circulation.

[13]  G. Specchia,et al.  Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology* , 2002 .

[14]  J. Herlitz,et al.  N-Terminal ProB – Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary Syndromes , 2002 .

[15]  D. Rothenbacher,et al.  Plasma Fibrin D-Dimer Levels and Risk of Stable Coronary Artery Disease: Results of a Large Case-Control Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[16]  M. Galvani,et al.  Prognostic role of hemostatic markers in acute coronary syndromes patients. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[17]  A. Siegbahn,et al.  Coagulation activity and clinical outcome in unstable coronary artery disease. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[18]  A. Siegbahn,et al.  Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. , 2000, The New England journal of medicine.

[19]  A. Bayés‐Genís,et al.  D-Dimer is an early diagnostic marker of coronary ischemia in patients with chest pain. , 2000, American heart journal.

[20]  E. Antman,et al.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. , 2000, JAMA.

[21]  A. von Eckardstein,et al.  D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction. , 1999, European heart journal.

[22]  L. Klein,et al.  Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications? , 1999, Journal of the American College of Cardiology.

[23]  R. Califf,et al.  Acute Coronary Syndromes in the GUSTO-IIb Trial Prognostic Insights and Impact of Recurrent Ischemia , 1998 .

[24]  H. Katus,et al.  Multicenter evaluation of a second-generation assay for cardiac troponin T. , 1997, Clinical chemistry.

[25]  L. Wallentin,et al.  Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. , 1997, Journal of the American College of Cardiology.

[26]  P. Ridker,et al.  Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. , 1994, Circulation.